Abstract:The DrugMatrix Database contains systematically generated toxicogenomics data from short-term in vivo studies for over 600 chemicals. However, most of the potential endpoints in the database are missing due to a lack of experimental measurements. We present our study on leveraging matrix factorization and machine learning methods to predict the missing values in the DrugMatrix, which includes gene expression across eight tissues on two expression platforms along with paired clinical chemistry, hematology, and histopathology measurements. One major challenge we encounter is the skewed distribution of the available measured data, in terms of both tissue sources and values. We propose a method, ToxiCompl, that applies systematic hybrid sampling guided by Bayesian optimization in conjunction with low-rank matrix factorization to recover the missing values. ToxiCompl achieves good training and validation performance from a machine learning perspective. We further conduct an in-depth validation of the predicted data from biological and toxicological perspectives with a series of analyses. These include examining the connectivity pattern of predicted gene expression responses, characterizing molecular pathway-level responses from sets of differentially expressed genes, evaluating known transcriptional biomarkers of tissue toxicity, and characterizing pre-dicted apical endpoints. Our analysis shows that the predicted differential gene expression, broadly speaking, aligns with what would be anticipated. For example, in most instances, our predicted differentially expressed gene lists offer a connectivity level comparable to that of measured data in connectivity analysis. Using Havcr1, a known transcriptional biomarker of kidney injury, we identify treatments that, based on the predicted expression data, manifest kidney toxicity in a manner that is mechanistically plausible and supported by the literature. Characterization of the predicted clinical chemistry data suggests that strong effects are relatively reliably predicted, while more subtle effects pose a greater challenge. In the case of histopathological prediction, we find a significant overprediction due to positivity bias in the measured data. Developing methods to deal with this bias is one of the areas we plan to target for future improvement. The main advantage of the ToxiCompl approach is that, in the absence of additional experimental data, it drastically extends the toxicogenomic landscape into a number of data-poor tissues, thereby allowing researchers to formulate mechanistic hypotheses about effects in tissues that have been underrepresented in the literature. All measured and predicted DrugMatrix data (i.e., gene expression, clinical chemistry, hematology, and histopathology) are available to the public through an intuitive GUI interface that allows for data retrieval, gene set analysis and high dimensional visualization of gene expression similarity ( ).

Gene Target Prediction of Environmental Chemicals Using Coupled Matrix-Matrix Completion

Completion of the DrugMatrix Toxicogenomics Database using ToxCompl

Predictive toxicology of chemical mixtures using proteome-wide thermal profiling and protein target properties

Cheminformatics Analysis of the Multitarget Structure-Activity Landscape of Environmental Chemicals Binding to Human Endocrine Receptors

Toxicity prediction using target, interactome, and pathway profiles as descriptors

Comprehensive hepatotoxicity prediction: ensemble model integrating machine learning and deep learning

In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project

Qualitative and Quantitative Concentration-Response Modelling of Gene Co-expression Networks to Unlock Hepatotoxic Mechanisms for Next Generation Chemical Safety Assessment

Chemical target and pathway toxicity mechanisms defined in primary human cell systems

Linking high resolution mass spectrometry data with exposure and toxicity forecasts to advance high-throughput environmental monitoring

HExpPredict: In Vivo Exposure Prediction of Human Blood Exposome Using a Random Forest Model and Its Application in Chemical Risk Prioritization

Deep Learning Bridged Bioactivity, Structure, and GC-HRMS-Readable Evidence to Decipher Nontarget Toxicants in Sediments

Identifying Protein Features and Pathways Responsible for Toxicity Using Machine Learning and Tox21: Implications for Predictive Toxicology

Accurate Clinical Toxicity Prediction using Multi-task Deep Neural Nets and Contrastive Molecular Explanations

A deep learning based multi-model approach for predicting drug-like chemical compound's toxicity

Scientific and methodological grounds for iterative prediction of risk and harm to human health under chemical environmental exposures: From protein targets to systemic metabolic disorders

Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing

Machine Learning Prediction of On/Off Target-driven Clinical Adverse Events

A Mechanistic Effect Modeling Approach to the Prioritization of Hidden Drivers in Chemical Cocktails.

Differential Reconstructed Gene Interaction Networks for Deriving Toxicity Threshold in Chemical Risk Assessment.

In Silico Prediction of Chemical Acute Dermal Toxicity Using Explainable Machine Learning Methods